Aarkstore.com | Emerging Cancer Vaccines Forecasts, Developments and Pipeline Analysis, 4th Edition

Document Sample
Aarkstore.com | Emerging Cancer Vaccines Forecasts, Developments and Pipeline Analysis, 4th Edition Powered By Docstoc
					Aarkstore.com announces, a new market research report is available in its vast collection:


       Emerging Cancer Vaccines: Forecasts, Developments and
                  Pipeline Analysis, 4th Edition
http://www.aarkstore.com/reports/Emerging-Cancer-Vaccines-Forecasts-Developments-
and-Pipeline-Analysis-4th-Edition-101728.html

The company has been researching and examining the development of cancer vaccines for seven
years. In April 2010, the cancer vaccine market experienced one of the biggest achievements in the
therapeutic vaccine treatment of cancer—the approval of the prostate cancer vaccine PROVENGE (TM).
This, in addition to the success of cervical cancer vaccine products, has created a viable market for
what was merely a speculative area just one decade ago.

Even with achievements for some companies, numerous vaccines with apparently strong prospects
have been hit by developmental delays and failures. These include CancerVax's Canvaxin, Aphton's
Insegia, Progenics' GMK vaccine, and Biomira's Theratope. Despite setbacks many developers are
hopeful of a turnaround. With a couple prophylactic vaccines for cervical cancer on the market, a few
select therapeutic vaccine approvals and several therapeutic vaccines on a promising path to
commercialization, the market could see a surge of regulatory activity and an influx of market
opportunities.

This Kalorama Information report - Emerging Cancer Vaccines: Forecasts, Developments and Pipeline
Analysis- focuses on both preventive and therapeutic cancer vaccines in development. The following
cancers for which there are vaccines in development or where there is a potential are profiled:

       Cervical

       Colon/Rectal

       Lung

       Lymphoma

       Melanoma

       Prostate

       Breast

       Gastrointestinal

       Renal

       Brain
       Bladder

       Ovarian

       Leukemia

The report includes statistical information for cancers by type worldwide, with special emphasis on the
U.S. market. Specifically, cancers where there is current vaccines development are profiled. Each
market segment provides an overview, descriptions of products available or in development, market
estimates and forecasts for 2010-2015, and competitive analysis of leading developers for 2015.

The report also includes current issues and trends affecting the industry.

This area of medicine is a new frontier and many of the issues that face the cancer vaccine market are
novel. However, this is a very promising area of medicine, which will continue to assist in the fight
against cancer.

Issues and trends discussed in The Emerging Cancer Vaccine Market include:

       Early Detection and Screening

       Monoclonal Antibodies and Therapeutic Vaccines

       Safety Concerns

       Insurance and Reimbursement Issues

       Personalized Medicine

       Pharmacogenomics

       Vaccine Strategies

       Economic Conditions and Vaccine Discovery

The information for this report was gathered using both primary and secondary research including
comprehensive research of secondary sources such as company literature, databases, investment
reports, and medical and business journals. Telephone interviews and email correspondence were the
primary method of gathering information.

More Related Reports :

World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)

Handhelds in Healthcare: Markets for Smartphones, Tablet PCs, PDAs, Monitors & Scanners

Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts)

Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
The World Market for Gastrointestinal Devices

Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market

Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of Asia

European Vaccine Markets: Germany, UK, France, Spain Italy, Rest of Europe

For More details about above & other Reports plz contact :

Aarkstore.com

Contact: Marketing team

Mob.No.918149852585

Email: enquiry@aarkstore.com

URL: http://www.aarkstore.com/

http://in.linkedin.com/in/aarkstore

http://www.facebook.com/aarkstore

				
DOCUMENT INFO
Description: The company has been researching and examining the development of cancer vaccines for seven years. In April 2010, the cancer vaccine market experienced one of the biggest achievements in the therapeutic vaccine treatment of cancer—the approval of the prostate cancer vaccine PROVENGE (TM).